Hamill John P. - Insider Non-Derivative Transactions at Aprea Therapeutics, Inc. (APRE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 28, 2024, Hamill John P.'s relationship to Aprea Therapeutics, Inc. (APRE) is Officer (SrVP/CFO/Prin Fin & Acct Ofcr), and currently has 18,868 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other APRE insiders.
Data Source: SEC.
Hamill John P. - Insider Non-Derivative Transactions of APRE Common Stock
Hamill John P. - Insider Non-Derivative Transactions at APRE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 29, 2024 | Acquisition -- (Common Stock) | 3365 | 0 | 18868 |
| Mar 14, 2024 | P -- (Common Stock) | 1010 | 7.29 | 15503 |
| Feb 28, 2023 | Acquisition -- (Common Stock) | 1000 | 5.25 | 14493 |
| Jan 31, 2023 | Acquisition -- (Common Stock) | 269879 | 0 | 269879 |